Three weeks post-op and fresh off her official physician follow-up appointment, host Ariana pulls back the curtain on the unexpected, complicated reality of what happens when surgery doesn't give you a clean, definitive "smoking gun."
In this deeply vulnerable and scientifically grounded episode of The Natural Navigator, we explore why normal pathology reports and atypical visuals can still happen when you've managed early-stage endometriosis with targeted progesterone therapy. Plus, we dive into the "sister disease" adenomyosis, the unexpected discovery of chronic fibrous inflammation on a colon biopsy, and how clinical research connects Ehlers-Danlos Syndrome, Mast Cell Activation, dysautonomia, and underlying autoimmune pathways.
In this episode, we explore:
- The psychological and physical reality of receiving "normal" biopsy results when your body has experienced real pain and surgery.
- The suppression factor: how proactive early intervention and progesterone therapy can halt early-stage (Stage 1) lesions in their tracks, modifying what pathology sees under the microscope.
- Adenomyosis 101: understanding the sister disease where endometrial-like tissue invades the muscular outer wall of the uterus, and its overlapping treatment approaches.
- The colon biopsy surprise: investigating chronic fibrous inflammation through the lens of the EDS-MCAS-dysautonomia triad and gut-immune crosstalk.
- Future directions: navigating potential autoimmune flags and coordinating with specialists like rheumatologists and gastroenterologists.
If this episode helped you feel less alone in the gray areas of chronic illness, please follow, leave a review on Apple Podcasts, or share it with a friend. Your body makes sense, and you are never alone.
Let's connect!
https://www.instagram.com/thenatural.navigator